ALLURION TECHNOLOGIES INC (ALUR)

Top movers in Friday's pre-market session

As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Allurion Receives Continued Listing Standards Notice from NYSE

Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity

Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors

Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program

Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial

Allurion Receives Continued Listing Standards Notice from NYSE

ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q2 2024

ALUR stock results show that Allurion Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Allurion Technologies (NYSE:ALUR) just reported results for the second quarter ...

Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement

Allurion Announces Launch of Offering of Common Stock and Warrants

Why Is Allurion (ALUR) Stock Up 140% Today?

Investors in ALUR stock are cheering today after Allurion announced some promising results for its key weight-loss program.

Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss

Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery

Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer

Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s

Allurion to Participate in Two Upcoming Investor Conferences in June 2024

Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss